Xtanly

Xtanly Updated 

Buy SNDL. CMP: $1.0 SL: 0.72 T1: $1.5 T2: $3.1 T3: $8.6

Xtanly

Looks like the base is formed and a reversal is on track. Target 1&2 - Dotted lines.

Xtanly Updated 

Qudian Inc. broke the daily and weekly resistances. CMP: $2.7 T1: $3.0 T2: $4.45 T3: $7.5 SL: $1.90

Xtanly Updated 

GBTC is probably topping out based on harmonic patterns

Xtanly Updated 

Forming a typical falling wave pattern, and breaking supports. Could rise up to the $5.0, but all rise must be sold. Very likely to go below $1.15

Xtanly Updated 

Compression of price within the short and medium-term trend lines. Price bounced from 200 MA & 50 EMA support and faced resistance of 9 & 21 EMA. 50 MA is about to cross down 9 & 21 EMA, and MACD is positive divergence. Expect a sharp breakout, SL = $0.8, target = trendlines.

Xtanly Updated 

This is a purely technical and the current market euphoria call. Expect $VBIV making $MRNA, $VIR like stratospheric moves. Target trend lines. SL: $2.6

Xtanly Updated 

Trade MRNA with caution and strict SL. It may blow past the resistance band, but there is a risk of a sharp turnaround due to the parabolic rise in price and valuation.

Xtanly Updated 

Bearish setup in S&P500. There was a -ve divergence, and the price had hit the trend line before the selloff in March. The setup is repeated, along with an expanding triangle pattern. It may give a throw over of a few % above the trend lines before going down.

Xtanly Updated 

Rising triangle has been broken on the upside. Upside is the base of the the of triangle, $10. It may reach ATH, ~$46.

Xtanly Updated 

Time to book profit or hold with trailing SL.

Xtanly Updated 

Antibe is either doing 'B' or has probably bottomed out. Trend lines and crossovers also support an up move. Very likely to hit the 1st target. Could hit the second and continue the up move if the +ve divergence stays.

Xtanly

Seers Inc received a bumper listing valuing it at $3.3 billion for a revenue of less than $1 million. It is claimed that company has a breakthrough for studying proteins and for diagnostics. Seers Inc received a bumper listing valuing it at $3.3 billion for revenue of less than $1 million. It is claimed that the company has a breakthrough for studying proteins...